HIV/TB – Case Studies David Schlossberg, MD, FACP Medical Director, TB Control Program Philadelphia Department of Health.

Slides:



Advertisements
Similar presentations
HIV & TB. Worldwide TB is the most important opportunistic infection in HIV patients – its the commonest killer. Around 20 million people worldwide are.
Advertisements

Tuberculosis and the Immune Reconstitution Inflammatory Syndrome (IRIS) Bob Colebunders.
A typical day in the TB clinic You see the following patients in the TB clinic. All have normal CXRs: 1. A 35 year old man from Hartford with a 16 mm positive.
June 2004 HITCH Training Slide Set #3 Special Considerations in Antiretroviral Therapy.
HIV and TB Co-infection Unit 14 HIV Basics: A Course for Physicians.
Global Health Case Studies – HIV and Tuberculosis Clinical Pearls in Diagnosis and Management Michael Tuggy, MD.
Continuity Clinic Tuberculosis. Continuity Clinic Objectives Know current epidemiologic trends in TB Know indications for testing for TB exposure and.
World Health Organization TB Case Definitions
Launch of Revised Strategy of TB- HIV Cross Referrals Delhi State AIDS Control Society Govt. of Delhi By Dr A.K. Gupta MD (Pediatrics) Additional Project.
HIV and TB Co-infection North Dakota HIV Symposium May 19, 2010 David McNamara, M.D. Clinical Assistant Professor of Medicine University of North Dakota.
Immune Reconstitution Inflammatory Syndrome (IRIS)
In the name of God Fariba Rezaeetalab Assistant Professor.
Unit 10 Treating the Dually Infected Patient: B Family Case Botswana National Tuberculosis Programme Manual Training for Medical Officers.
Pleural TB. Case 2  33y Male Smoker (10 pack) Aboriginal  1 Month Cough, SOBE,Fever  Cough non productive  No orthopnea, PND, LL swelling  Fever.
TB and HIV Coinfection Bruce A. Bush, M.D.
Diagnosis of TB.
Unit 5: IPT Isoniazid TB Preventive Therapy
Natural History and Clinical Staging of HIV Training for Medical Officers Day 2 Session 7.
The danger Numero Uno. That’s how it reaches you Unprotected sexual intercourse Intravenous drug abuse and shared needles From a HIV positive mother to.
HIV: Acute (Primary) Infection. David H
A cost-effectiveness evaluation of preventive interventions for HIV-TB in Sub-Saharan Africa (Tanzania): Relevance for neurological infections Lucie Jean-Gilles.
“Don’t tell me TB is under control!” Understanding TB
HAIVN Harvard Medical School AIDS Initiative in Vietnam
Increasing HIV treatment for TB patients – thinking out of the box Anthony D Harries, The Union Paris, France.
Unit 9 Diagnosis and Treatment of Paediatric TB: B Family Case Botswana National Tuberculosis Programme Manual Training for Medical Officers.
1 Respiratory Diseases in HIV-infected Patients HAIVN Harvard Medical School AIDS Initiative in Vietnam.
TUBERCULOSIS IN THE AGE OF HIV Dr. Terry Baker Physician National Chest Hospital.
The effects of tuberculosis on PLWHA Prof Helmuth Reuter Ukwanda Centre for Rural Health and Desmond Tutu TB Centre Stellenbosch University.
IAS–USA When to Start Antiretroviral Therapy Constance A. Benson, MD Professor of Medicine University of California San Diego FINAL: Presented.
1 Bacille Calmette-Guerin Vaccine-Induced Disease in Children with HIV/AIDS HAIVN Harvard Medical School AIDS Initiatives in Vietnam.
HIV related Opportunistic Diseases HIV related Opportunistic Diseases M.MEIDANI,MPH.MD.
Tuberculosis Egan’s Chapter 22. Mosby items and derived items © 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 2 Tuberculosis (TB) The incidence of.
Treatment of Tuberculosis: New Case Case Studies Module 7A2 – March 2010.
V IRGINIA C OHORT D ATA – 5 YEAR TRENDS AFTER 4 YEARS OF LOCAL COHORT REVIEW Virginia achievement on National TB Indicators for the past 5 years – where.
1 Tuberculosis and HIV HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Coordinator: Kézdi- Zaharia E. Iringó First author: Magyar Júlia Coauthor: Gyerő Réka.
Welcome to I-TECH HIV/AIDS Clinical Seminar Series November 19, 2009 Tuberculosis in Persons with HIV/AIDS: Opportunities for Prevention Charles Nolan,
HIV/TB Integration in a Network of Voluntary Counseling/Testing Centers in HAITI Reynold Grand’Pierre MD, Marie Suze Jacquet MD, Jean W. Pape MD PEPFAR.
1 HIV Clinical Staging HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Module 2 TB Disease Transmission & Prevention. Pulmonary Tuberculosis Extra -Pulmonary TB an infectious disease caused by a microorganism called Mycobacterium.
Diagnostic Tests Chest x-ray –Patchy or nodular infiltrate –Apical or sub-apical posterior aspects of UPPER LOBES (or superior segment of lower.
Unit 5 Isoniazid Prevention Therapy: B Family Case Botswana National Tuberculosis Programme Manual Training for Medical Officers.
Tuberculosis August 17, 2010 Tuberculosis Mycobacterium tuberculosis – Fastidious, aerobic, acid-fast bacillus Tremendous increase in incidence over.
Prophylaxis of Opportunistic Infections
Q1 Which of the following descriptions about HIV and TB interaction is right ? Which of the following descriptions about HIV and TB interaction is right.
Active or inactive? Anti-TB treatment or not? Etienne Leroy Terquem – Pierre L’Her SPI / ISP Soutien Pneumologique International / International Support.
California Update : TB Epidemiology and Indicators CTCA October 22, 2010 Jennifer Flood MD MPH Chief, Surveillance and Epidemiology Tuberculosis Control.
Extrapulmonary tuberculosis and HIV Outi Vehviläinen, MD Ilembula Lutheran Hospital
Sunil Kumar, B.K.Kapoor, Urvinderpal Singh, Vidhu Mittal Department of Pulmonary Medicine, GMC,Patiala PRESENTATION OF PULMONARY TUBERCULOSIS IN ELDERLY.
TB Prevention and Control in Correctional and Detention Facilities Mark Lobato, MD Division of TB Elimination Centers for Disease Control and Prevention.
Inflammation Case Presentation
Tuberculosis in Children and Young Adults
Human Immune Deficiency Virus Infection Dr Huda Taha Sep 2015.
LEARNING MODULE TITLE SUBTITLE. HISTORY OF PRESENT ILLNESS An 18 year-old woman with no past medical history and no known risks for TB presents with several.
TB IN CHILDREN & PREGNANT WOMEN
Case Discussion 1 - TREATMENT OF TB IN ADULTS by Dr. Razul Md Nazri Md Kassim 1.
FOLLOW-UP, REFERRAL & COMMON ADR OF ANTITB TREATMENT by Assoc. Prof. Dr. Tengku Saifudin Tengku Ismail Ms. Rahela Ambaras Khan 1.
Post-arrival TB Screening of the High-Risk Refugees and Immigrants in Maryland Natasha Chida, MD MSPH Baltimore City Health Department March 22 nd, 2016.
TB-H V Co-infection by Dr. Ker Hong Bee 11. LEARNING OBJECTIVES To know & understand about TB-HIV co- infection in relation to:- – interaction & prevalence.
Tuberculosis in Children: Treatment and Monitoring Module 10B - March 2010.
Case Discussion 2 - TB IN CHILDREN by Dr. Jeyaseelan P. Nachiappan & Dr. Suryati Adnan 1 Picture of CPG Cover.
OB/GYN Review Course: Women and HIV Questions Peter G. Gulick, DO, FACP, FACOI Associate Professor.
Sarah Al-Obaydi M.B.Ch.B, MPH(c) Fulbright scholar.
Management of the Newborn When Maternal TB Suspected
14/02/1396.
This is an archived document.
Dr Dawood Quiz questions.
Management of Immune Reconstitution Inflammatory Syndrome (IRIS)
Surveillance for TB in HIV Care and Treatment Settings (CTS)
Presentation transcript:

HIV/TB – Case Studies David Schlossberg, MD, FACP Medical Director, TB Control Program Philadelphia Department of Health

A 23 year-old African-American man presents with a 3-week history of fever, cough and 15 pound weight loss. He admits to IVDA. Physical exam is unremarkable except for fever. Routine cultures are negative, but AFB smear of sputum is positive. HIV serology is positive, with CD4 = 120. Case # 1

TB in AIDS – Be suspicious! Often initial manifestation of AIDS ANY respiratory symptoms –Suspect even with clear CXR Subclinical: NO resp symptoms and clear CXR – Ten Tanzanian patients (2%) with CD4 >200 Cultures positive in 10/10 Smears negative in 7/10 Mtei et al, Clin Infect Dis 2005;40:1500-7

TB in Advanced AIDS Frequently atypical: –CXR: clear, mid and lower lung zones, effusion, adenopathy –Extrapulmonary involvement common – up to 70%: lymphadenopathic, meningeal, hepatic, renal, pleural, cutaneous, spinal, miliary –PPD negative > 60% –Exogenous reinfection possible May > reactivation in some sub-groups

Anti-TB Rx in HIV Same as in HIV- negative patients, except: –Avoid once-weekly continuation phase –Avoid twice-weekly Rx if CD4 <100 –Nine months if culture positive after 2 mos –Six-month minimum, even for culture-negative Good response to therapy; early mortality may be high, but relapse rate < 5% Drug interactions (rifamycins) (

A 29 year-old Hispanic woman with AIDS is on HAART. Her viral load is undetectable, and her CD4 count is 550. She was recently exposed to a cousin with TB, and her PPD is 17x20mm. She is asymptomatic, and her CXR is normal. She just found out she is pregnant. Case # 2

LTBI in HIV HIV and TB feed on each other –Immunosuppression is a risk for progression to TB –MTB induces replication of HIV Progression of LTBI to TB disease: –Nosocomial outbreak: 35% within 60 days –10% per year (vs. 10% lifetime risk if HIV-negative)

Therefore, treat LTBI aggressively –Pregnancy - any stage –Even with history of prior treatment –Even for contacts with negative PPD –9 months preferable to 6 months

Case # 3 A nineteen-year-old white male IVDA presented with cavitary pulmonary TB and was found to be HIV-positive (CD4 = 275). Both HAART and anti-TB Rx were initiated, with good clinical response. However, after 3 weeks, he developed fever, new pulmonary infiltrates and intrathoracic lymphadenopathy.

Lung infiltrate Lymphadenitis Intracranial tuberculoma Subcutaneous abscess Etc., etc., etc. Immune Reconstitution Syndrome (Paradox, “HAART Attacks”) HAART + anti-TB Rx: up to 35%

Vidal J, et. al. Rev. Inst. Med. Trop. S. Paulo vol.45 no.3 São Paulo May/June 2003

Subcutaneous abscess – Immune Reconstitution in patient with AIDS And Miliary TB, on HAART

Management of IRIS Rule out other causes Continue ART and anti-TB Rx Treat symptomatically –NSAIDS –Corticosteroids

Try to Prevent IRIS: Already on ART – just add anti-TB Rx Simultaneous Dx of HIV plus TB: –CD4 > Start Anti-TB Rx + ART –CD4 < Rx TB; Delay ART 4-8 weeks CD4 < 50 - some would start both ART + Anti-TB Rx

Take-Home Points: HIV + TB TB is common Immunosuppression causes unusual presentations LTBI progression to TB is significant risk Drug interactions are frequent IRIS may mimic treatment failure or new infection

Thank You!